M. Zhang et al. / Steroids xxx (2015) xxx–xxx
3
2.3. Extraction and isolation
2.3.4. Compound 4
22
White amorphous powder; [
a]
+3.2 (c 2.01, MeOH); UV
D
The air-dried roots of C. otophyllum (9.0 kg) were extracted with
EtOH (75%) for three times (3 h, 10 L ꢀ3). The organic solvent was
removed at vacuum, and the residue suspended in water (10 L).
Then, it was extracted with CHCl3 (5 L ꢀ4) to afford CHCl3 soluble
fraction (240 g). CHCl3 extract (240 g) was subjected to a silica gel
(15 cm ꢀ 100 cm) column and eluted with CHCl3–MeOH (40:1,
20:1, 10:1, 5:1, v/v) to get six fractions (Frs. 1–6). Purification
was focused on Frs. 2–5 by mainly methods of semi-preparative
HPLC. Fr. 2 (30.5 g) was separated by MCI CC with MeOH–H2O
(85:15 ? 75:25, v/v) to give five fractions (Frs. 2A–2F). Fr. 2A
was subjected to ODS CC with MeOH–H2O (85:15 ? 80:20, v/v)
to give three fractions (Frs. 2A1–2A3). Frs. 2A3 was performed on
preparative HPLC and eluted with MeOH–H2O (85:15 ? 82:18 ?
80:20, v/v) to yield 15 (9.4 mg, Rt = 33.5 min), 10 (60.2 mg,
Rt = 35.3 min), 2 (7.5 mg, Rt = 38.4 min), 18 (6.5 mg, Rt = 42.0 min),
1 (10.1 mg, Rt = 45.2 min) and 9 (66.3 mg, Rt = 47.8 min). Fr. 2B
was separated by ODS CC with MeOH–H2O (83:17 ? 78:22, v/v)
to give two fractions (Frs. 2B1–2B2). Frs. 2B1–2B2 were purified
by preparative HPLC, eluted with MeOH–H2O (80:20 ? 78:22, v/
v) to yield 26 (10.1 mg, Rt = 45.9 min), 3 (110 mg, Rt = 50.4 min),
5 (48.3 mg, Rt = 55.6 min) and 16 (30.2 mg, Rt = 60.5 min). Fr. 2D
was purified by preparative HPLC with MeOH–H2O (77:23, v/v)
to yield 25 (5.6 mg, Rt = 36.9 min), 24 (22.3 mg, Rt = 40.3 min), 23
(13.2 mg, Rt = 45 min) and 13 (5.4 mg, Rt = 50.3 min). Fr.3 was sub-
jected to ODS CC with MeOH–H2O (80:20 ? 76:24, v/v) to give
three fractions (Frs. 3A1–3A3). Frs. 3A1 was performed on prepar-
ative HPLC, eluted with MeOH–H2O (76:24, v/v) to yield 17
(40.1 mg, Rt = 43.9 min), 7 (23.3 mg, Rt = 46.1 min), 8 (12.5 mg,
Rt = 50.9 min) and 19 (20.1 mg, Rt = 55.8 min). Fr. 4 was subjected
to ODS CC with MeOH–H2O (78:22 ? 74:26, v/v) to give four frac-
tions (Frs. 4A1–4A4). Fr. 4A2 was performed on preparative HPLC,
eluted with MeOH–H2O (77:23 ? 75:25 ? 74:26, v/v) to obtain 14
(18.1 mg, Rt = 40.5 min), 6 (13.4 mg, Rt = 45.9 min), 20 (8.5 mg,
Rt = 48.9 min) and 12 (40.9 mg, Rt = 57.9 min). Fr. 5 was subjected
to ODS CC with MeOH–H2O (75:25 ? 70:30, v/v) to give two frac-
tions (Frs. 5A1–5A2). Fr. 5A1 was performed on preparative HPLC,
eluted with MeOH–H2O (73:27, v/v) to yield 22 (4.1 mg,
(MeOH) kmax (loge) 220 (3.58) nm; IR (KBr) õmax 3461, 2969, 2934,
1713, 1643, 1451, 1384, 1369, 1317, 1224, 1166, 1084, 1007, 912,
864; HRESIMS m/z 947.4976 ([M+Na]+, C48H76O17Na, calcd.
947.4974). 1H NMR (C5D5N, 500 MHz) and 13C NMR (C5D5N,
125 MHz) see Tables 1–3.
2.3.5. Compound 5
21
White amorphous powder; [
a
]
+2.6 (c 1.16, MeOH); UV
D
(MeOH) kmax (log
e
) 224 (3.92) nm; IR (KBr) õmax 3442, 2968, 2934,
1713, 1641, 1450, 1385, 1370, 1317, 1224, 1165, 1063, 1004, 912,
865; HRESIMS m/z 1075.5810 ([M+Na]+, C55H88O19Na, calcd.
1075.5812). 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3,
125 MHz) see Tables 1–3.
2.3.6. Compound 6
22
White amorphous powder; [
(MeOH) kmax (log
a]
ꢁ67.2 (c 1.05, MeOH); UV
D
e
) 219 (3.74) nm; IR (KBr) õmax 3445, 2969, 2932,
1714, 1641, 1452, 1384, 1367, 1316, 1223, 1164, 1055, 1005, 913,
865; HRESIMS m/z 1075.5815 ([M+Na]+, C55H88O19Na, calcd.
1075.5812). 1H NMR (C5D5N, 500 MHz) and 13C NMR (C5D5N,
125 MHz) see Tables 1–3.
2.3.7. Compound 7
22
White amorphous powder; [
(MeOH) kmax (log
a]
+7.8 (c 1.60, MeOH); UV
D
e
) 219 (3.75) nm; IR (KBr) õmax 3452, 2969, 2933,
1714, 1643, 1451, 1383, 1368, 1317, 1223, 1164, 1059, 1004, 912,
864; HRESIMS m/z 1105.5912 ([M+Na]+, C56H90O20Na, calcd.
1105.5917). 1H NMR (C5D5N, 500 MHz) and 13C NMR (C5D5N,
125 MHz) see Tables 1–3.
2.3.8. Compound 8
White amorphous powder; [
(MeOH) kmax (log
22
a]
ꢁ2.2 (c 1.63, MeOH); UV
D
e
) 230 (3.98) nm, 225 3.95)nm; IR (KBr) õmax
3447, 2968, 2934, 1712, 1641, 1450, 1384, 1369, 1317, 1224, 1166,
1061, 1004, 910, 866; HRESIMS m/z 1219.6604 ([M+Na]+,
C
62H100O22Na, calcd. 1219.6598). 1H NMR (C5D5N, 500 MHz) and
Rt = 33.9 min), 21 (13.2 mg, Rt = 36.3 min),
Rt = 42.9 min) and 11 (20.3 mg, Rt = 46.9 min).
4
(60.2 mg,
13C NMR (C5D5N, 125 MHz) see Tables 1–3.
2.3.9. Compound 9
2.3.1. Compound 1
21
21
White amorphous powder; [
(MeOH) kmax (log
a]
ꢁ9.9 (c 1.00, MeOH); UV
D
White amorphous powder; [
(MeOH) kmax (log
a]
ꢁ4.7 (c 1.06, MeOH); UV
D
e
) 220 (3.93) nm; IR (KBr) õmax 3443, 2969, 2932,
e
) 226 (3.86) nm; IR (KBr) õmax 3442, 2965, 2933,
1714, 1642, 1452, 1382, 1368, 1317, 1223, 1165, 1065, 1004, 912,
864; HRESIMS m/z 1377.7556 ([M+Na]+, C70H114O25Na, calcd.
1377.7552). 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3,
125 MHz) see Tables 1–3.
1713, 1641, 1450, 1384, 1368, 1316, 1224, 1166, 1063, 1004, 911,
863; HRESIMS m/z 945.5180 ([M+Na]+, C49H78O16Na, calcd.
945.5182). 1H NMR (CDCl3, 500 MHz) and 13C NMR (CDCl3,
125 MHz) see Tables 1–3.
2.3.10. Compound 10
2.3.2. Compound 2
White amorphous powder; [
(MeOH) kmax (log
21
22
White amorphous powder; [
(MeOH) kmax (log
a]
+9.9 (c 1.08, MeOH); UV
a
]
D
ꢁ5.9 (c 3.46, MeOH); UV
D
e
) 259 (3.57) nm; IR (KBr) õmax 3447, 2972, 2934,
e
) 228 (3.83) nm, 225 (3.81) nm; IR (KBr) õmax
1711, 1610, 1596, 1515, 1451, 1382, 1310, 1276, 1167, 1087, 1059,
911, 856, 772; HRESIMS m/z 1101.5242 ([M+Na]+, C55H82O21Na,
calcd. 1101.5240). 1H NMR (C5D5N, 500 MHz) and 13C NMR
(C5D5N, 125 MHz) see Tables 4–6.
3443, 2965, 2932, 1713, 1641, 1450, 1384, 1369, 1315, 1224, 1165,
1065, 1005, 913, 862; HRESIMS m/z 961.5140 ([M+Na]+, C49H78O17Na,
calcd. 961.5141). 1H NMR (C5D5N, 500 MHz) and 13C NMR (C5D5N,
125 MHz) see Tables 1–3.
2.3.3. Compound 3
2.3.11. Compound 11
22
22
White amorphous powder; [
a
]
+2.8 (c 1.04, MeOH); UV
White amorphous powder; [
a
]
ꢁ25.5 (c 1.32, MeOH); UV
D
D
(MeOH) kmax (log
e
) 224 (3.87) nm, 226 (3.86) nm; IR (KBr) õmax
(MeOH) kmax (loge) 214 (4.00) nm, 259 (3.51) nm; IR (KBr) õmax
3453, 2968, 2933, 1713, 1642, 1451, 1384, 1368, 1317, 1224, 1167,
1059, 1005, 912, 864; HRESIMS m/z 961.5134 ([M+Na]+, C49H78O16Na,
calcd. 961.5141). 1H NMR (C5D5N, 500 MHz) and 13C NMR (C5D5N,
125 MHz) see Tables 1–3.
3451, 2972, 2933, 1711, 1611, 1515, 1452, 1383, 1311, 1276, 1164,
1099, 1057, 912, 853, 773; HRESIMS m/z 1099.5448 ([M+Na]+,
C
56H84O20Na, calcd. 1099.5446). 1H NMR (C5D5N, 500 MHz) and
13C NMR (C5D5N, 125 MHz) see Tables 4–6.
Please cite this article in press as: M. Zhang et al., Cytotoxicity of pregnane glycosides of Cynanchum otophyllum, Steroids (2015), http://dx.doi.org/10.1016/